Showing results (2061-2070 of 10,388) with videos related to

Sort By:
Pageof 1,039
Vaccines|January 22, 2024
Exploring Perceptions and Practices Regarding Adult Vaccination against Seasonal Influenza, Tetanus, Pneumococcal Disease, Herpes Zoster and COVID-19: A Mixed-Methods Study in GreeceIordanis Avramidis, Ilias Pagkozidis, Philippe-Richard J Domeyer, et al.
Vaccines|January 22, 2024
Latent Class Analysis Identifies Distinct Phenotypes of Systemic Lupus Erythematosus Predictive of Flares after mRNA COVID-19 Vaccination: Results from the Coronavirus National Vaccine Registry for ImmuNe Diseases SINGapore (CONVIN-SING)Tao Ming Sim, Manjari Lahiri, Margaret Ma, et al.
Vaccines|January 22, 2024
Neutralizing Antibody Response following a Third Dose of the mRNA-1273 Vaccine among Cancer PatientsChristopher W Dukes, Marine Potez, Jeffrey Lancet, et al.
Vaccines|January 22, 2024
Measuring Variant-Specific Neutralizing Antibody Profiles after Bivalent SARS-CoV-2 Vaccinations Using a Multivariant Surrogate Virus Neutralization MicroarrayDavid Niklas Springer, Eva Höltl, Katja Prüger, et al.
Vaccines|January 22, 2024
Predictors of Breakthrough SARS-CoV-2 Infection after VaccinationSharon Walmsley, Majid Nabipoor, Leif Erik Lovblom, et al.
Vaccines|January 22, 2024
Modeling Supply and Demand Dynamics of Vaccines against Epidemic-Prone Pathogens: Case Study of Ebola Virus DiseaseDonovan Guttieres, Charlot Diepvens, Catherine Decouttere, et al.
Vaccines|January 22, 2024
A Potential Association between Abdominal Obesity and the Efficacy of Humoral Immunity Induced by COVID-19 and by the AZD1222, Convidecia, BNT162b2, Sputnik V, and CoronaVac VaccinesJavier Angeles-Martinez, Irma Eloisa Monroy-Muñoz, José Esteban Muñoz-Medina, et al.
Vaccines|January 22, 2024
Humoral Response and Safety after a Fourth Dose of the SARS-CoV-2 BNT162b2 Vaccine in Cancer Patients Undergoing Active Treatment-Results of a Prospective Observational StudyChiara Citterio, Claudia Biasini, Camilla Di Nunzio, et al.
Vaccines|February 24, 2024
Serial Llama Immunization with Various SARS-CoV-2 RBD Variants Induces Broad Spectrum Virus-Neutralizing NanobodiesPavel P Solodkov, Alexander M Najakshin, Nikolai A Chikaev, et al.
Vaccines|February 24, 2024
Assessing a Digital Scorecard on Global Immunization Progress: Stakeholder Views and Implications for Enhancing Performance and AccountabilityRose Weeks, Padmini Vishwanath, Katy Atkins Stewart, et al.
Pageof 1,039